ResApp share price explodes 50% on new Pfizer deal

The ResApp share price is launching upwards after Pfizer upped its takeover bid for the company.

| More on:
A woman wakes up after sleeping soundly, stretching her arms high sitting in bed.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The ResApp share price surged to a new 52-week high of 19 cents today, representing a 58% gain
  • It came on the back of news Pfizer had upped its bid for the company to 20.8 cents per share
  • That values ResApp at around $179 million

The ResApp Health Ltd (ASX: RAP) share price is leaping on news Pfizer has upped its bid for the company.

The biopharmaceutical giant has agreed to acquire the Brisbane-based health technology company for 20.8 cents per share. That's up from its previous bid of 14.6 cents.

The ResApp share price is trading at 18 cents right now, 50% higher than its previous close.

However, that's lower than its intraday high – and new 52-week high – of 19 cents.

Let's take a closer look at the latest news from the takeover target.

ResApp share price takes off on upped takeover offer

The ResApp share price is soaring 50% on Wednesday after the company announced Pfizer has upped its takeover bid to 20.8 cents per share.

That sits within its assessed value range of 14.6 cents to 27.9 cents per ResApp share, as determined by an independent expert. It also values the company at around $179 million.

The pair have entered an amended scheme of arrangement agreement entailing the increased bid.

ResApp recommends shareholders vote in favour of the proposition in the absence of a superior proposal and subject to the independent expert continuing to conclude that the scheme is in investors' best interests.

How did we get here?

ResApp is the developer of a smartphone app designed to detect COVID-19 using cough sounds.

The tech was recently dealt a blow when a data confirmation study returned significantly worse results than a previous pilot study.

Pfizer first put a takeover proposal to ResApp in April. Then, it offered just 11.5 cents per share.

That bid was upped to either 20.7 cents or 14.6 cents in June. Though, the higher of the bids was dependent on positive findings from the data confirmation study, which hadn't been completed at the time.

Perhaps unsurprisingly, the ResApp share price plummeted 28.6% when the study's disappointing results were released.

Should you invest $1,000 in Aeris Resources Limited right now?

Before you buy Aeris Resources Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Aeris Resources Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX All Ords tech stock just rocketed 30% on takeover news

The ASX All Ords tech stock is bucking the broader tech sell-off today to rocket higher.

Read more »

a mine worker holds his phone in one hand and a tablet in the other as he stands in front of heavy machinery at a mine site.
Mergers & Acquisitions

Fortescue shares slide on $254m Pilbara acquisition

This mining giant is making a new acquisition. Here's what it has announced.

Read more »

Mergers & Acquisitions

Myer shares race higher on 'overwhelming support' for merger

The department store expects the merger to create a stronger business.

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Insignia Financial shares: When will the bidding war end?

Bidding action for the ASX 200 financial stock continues today.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Mergers & Acquisitions

How Rio Tinto shares could eclipse BHP in 2025, with a little help from Glencore

The financial rumour mill is abuzz about a potential mega merger for Rio Tinto.

Read more »

A man wearing a shirt, tie and hard hat sits in an office and marks dates in his diary.
Materials Shares

BHP share price higher on US$2b acquisition to support artificial intelligence market

BHP is ready to step up and help support the booming AI megatrend.

Read more »

A woman in a business suit and a man in a business suit boxing in a ring.
Financial Shares

ASX 200 financial stock races higher amid takeover bidding war

This stock has received competing takeover bids this month.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Materials Shares

Why this $10 billion ASX lithium stock is surging 8% today

This lithium miner is making its shareholders smile on Thursday. But why?

Read more »